These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12140124)

  • 1. Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
    Kellner M; Yassouridis A; Hua Y; Wendrich M; Naber D; Wiedemann K
    Psychiatry Res; 2002 Aug; 111(1):93-6. PubMed ID: 12140124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
    Aluoja A; Shlik J; Vasar V; Kingisepp PH; Jagomägi K; Vasar E; Bradwejn J
    Psychiatry Res; 1997 Jan; 66(1):59-67. PubMed ID: 9061804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D; Copen J; Bradwejn J
    J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
    Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of state and trait anxiety on the panic response to CCK-4.
    Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
    J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms.
    Kellner M; Zwanzger P; Rupprecht R; Eser D; Yassouridis A; Wiedemann K
    Psychoneuroendocrinology; 2019 Dec; 110():104433. PubMed ID: 31525566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental panic provocation in healthy man-a translational role in anti-panic drug development?
    Kellner M
    Dialogues Clin Neurosci; 2011; 13(4):485-93. PubMed ID: 22275853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P; Eser D; Padberg F; Baghai TC; Schule C; Rötzer F; Ella R; Möller HJ; Rupprecht R
    Depress Anxiety; 2003; 18(3):140-3. PubMed ID: 14625878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
    Bradwejn J; Koszycki D
    Am J Psychiatry; 1994 Feb; 151(2):261-3. PubMed ID: 8296900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.
    Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H
    Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E; Tõru I; Vasar V; Shlik J
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K; Jahn H; Yassouridis A; Kellner M
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety sensitivity and cholecystokinin tetrapeptide challenge.
    McNally RJ
    Am J Psychiatry; 1995 Feb; 152(2):300-1. PubMed ID: 7840376
    [No Abstract]   [Full Text] [Related]  

  • 16. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D; Cox BJ; Bradwejn J
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.
    Le Mellédo JM; Arthur H; Dalton J; Woo C; Lipton N; Bellavance F; Koszycki D; Boulenger JP; Bradwejn J
    J Psychosom Res; 2001 Sep; 51(3):513-20. PubMed ID: 11602221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J; Koszycki D; Shriqui C
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
    Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.